Clinical Outcome Evaluation of Glycaemic Control in a Metformin-based Therapy of Type 2 Diabetes Mellitus Patients Managed Under Ambulatory Care Settings
Journal Title: Journal of Pharmaceutical Research International - Year 2016, Vol 12, Issue 5
Abstract
Background: Short term clinical outcomes evaluation of glycaemic goals or its control are desirable to monitor response to therapy in individual patients and to identify compliance or other problem areas. Aim and Objectives: The objectives of this study are to determine the levels of glycaemic control between clinic visits, determine changes in diabetes status during consecutive clinic visits and to evaluate the degree of decrease or otherwise in fasting blood sugar of patients. Results: The fasting blood sugar (FBS) during consecutive clinic visits showed hypoglycaemia increased from 1.0% during the first visit to 3.3% during the fifth visit. Normal glycaemic levels increased from 15.0% during first clinic visits to 23.3% at fifth visits. About 18.2% of the FBS were maintained at impaired glucose concentration range. The proportion of patients whose FBS was in the diabetic range decrease progressively (P<0.05) from 72.0% during the first visit to 50.0% at the fifth visit. The distributions in glycaemic levels during the entire periods are hypoglycaemia (1.4%), normal range (19.4%), impaired glucose concentration (18.2%) and diabetic range (61.4%). In 98 (24.0%) cases, the changes which occurred was from higher diabetic range to lower diabetic range with mean change of 14.12±4.84 to 10.28±3.13 mMol/L. Other changes are from diabetic range to impaired glucose concentration range with mean change of 10.47±3.07 to 6.55±2.98 mMol/L(P<0.01); diabetic range to normal range (mean change from 9.98±3.10 to 4.96±0.61 mMol/L; P<0.01) and from impaired glucose concentration to normal range (mean FBS change from 6.31±0.43 to 4.75±0.74 mMol/L; P<0.01). Changes involving increase in FBS occurs from normal range to diabetic range (4.60±0.66 to 10.76±3.71 mMol/L; P<0.01), impaired glucose concentration to diabetic range (6.43±0.36 to 9.87±2.95 mMol/L; P<0.01) and diabetic range to higher diabetic value (11.66±3.73 to 14.66±5.03 mMol/L; P<0.01). Conclusion: Most patients recorded decrease in FBS over values recorded in their previous clinic visits but these changes do not translate to good glycaemic control. Several patients experiences poor glycaemic control probably as a result of non-compliance. Multiple clinic visits also do not translate to the desired glycaemic control.
Authors and Affiliations
John David Ohieku, Joy Bitrus Musa, Onoja Ameh
Anti-inflammatory Activity of Cucumis sativus L.
Aims: To evaluate the anti-inflammatory activity and acute toxicity of Cucumis sativus L. Study Design: Animal model assays of anti-inflammatory. Place and Duration of Study: Department of Biochemistry, University of Ni...
Central Nervous System Depressant Effect of Senna occidentalis Linn. (Fabaceae) Leaf Extract in Mice
Senna occidentalis has been used in traditional medicine in Nigeria for managing various ailments in traditional medicine. This study was aimed at evaluating the central nervous system depressant effect of ethanol leaf e...
Effect of Formulation Variables on the Release of Letrozole from Natural Biodegradable Polymeric Implants
Aim: Letrozole, a non-steroidal aromatase inhibitor, prevents the body from producing its own estrogen. The objective of the present study was to explore the fabrication and evaluation of natural biodegradable polymeric...
Efficacy of Commercially Used Antibacterial Agents against Oral Bacteria Associated with HIV/AIDS Patients in South Western Uganda
Aims: This was to determine efficacy and resistance profiles against commonly used commercial antibacterial agents in Uganda in the management of oral pathogens in HIV/AIDS patients. Study Design: This was an experimenta...
Cytotoxic and Hepatoprotective Effects of Bupleurum flavum Flavonoids on Hepatocellular Carcinoma HEP-G2 Cells
Aims: In this study, we aimed at investigating the possible cytotoxic and hepatoprotective effects of crude extract, flavonoid mixture and pure flavonoids isolated from the aerial parts of Bupleurum flavum Forsk. (Apiace...